Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2012

01-03-2012 | Clinical Research

Prevalence and Co-occurrence of Upper and Lower Functional Gastrointestinal Symptoms in Patients Eligible for Bariatric Surgery

Authors: Marinos Fysekidis, Michel Bouchoucha, Hélène Bihan, Gérard Reach, Robert Benamouzig, Jean-Marc Catheline

Published in: Obesity Surgery | Issue 3/2012

Login to get access

Abstract

Background

Obesity is considered as a risk factor for many functional digestive disorders. The aim of the present study was to evaluate the prevalence and the association of functional digestive symptoms affecting the upper and the lower digestive tract in patients eligible for bariatric surgery.

Methods

Before surgery, 120 consecutive patients with normal upper endoscopy (7.5% males, mean BMI 44 ± 6 m/kg2) have filled a standard questionnaire in order to evaluate the presence of depressive symptoms and functional digestive disorders according to the Rome criteria. The major symptoms (esophageal, gastroduodenal, anorectal, and abdominal pain) were coded as dichotomous variables. Data analysis was performed using multivariate logistic regression with a backwards selection procedure adjusted only for the variables that were significant in univariate analysis (p < 0.05).

Results

Functional symptoms were present in 89% of the subjects (2.5 functional digestive symptoms/subject). Depression symptoms were found in 43% of the patients. Esophageal symptoms were independent predictors for the presence of gastric, bowel, and anorectal symptoms. Functional abdominal pain and bowel symptoms were present, respectively, in 19% and 84% of the patients. Approximately half of the patients have specific functional bowel disorders (28.6% constipation, 18% irritable bowel syndrome, 18% diarrhea, 1% bloating) and 35.7% have non-specific bowel disorders. Anorectal symptoms were found in 40% of the patients: difficult defecation in 32% and fecal incontinence in 9.8% of the patients. Depression was an independent predictor for anorectal symptoms.

Conclusions

This study shows the high prevalence of functional bowel symptoms in patients complaining of morbid obesity.
Literature
1.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377–90.PubMedCrossRef
2.
Galmiche JP, Clouse RE, Balint A, et al. Functional esophageal disorders. Gastroenterology. 2006;130(5):1459–65.PubMedCrossRef
3.
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79.PubMedCrossRef
4.
Ford AC, Forman D, Bailey AG, et al. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut. 2007;56(3):321–7.PubMedCrossRef
5.
Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.PubMedCrossRef
6.
Clouse RE, Mayer EA, Aziz Q, et al. Functional abdominal pain syndrome. Gastroenterology. 2006;130(5):1492–7.PubMedCrossRef
7.
Bharucha AE, Wald A, Enck P, et al. Functional anorectal disorders. Gastroenterology. 2006;130(5):1510–8.PubMedCrossRef
8.
Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet. 2009;374(9683):65–75.PubMedCrossRef
9.
Popkin BM. What can public health nutritionists do to curb the epidemic of nutrition-related noncommunicable disease? Nutr Rev. 2009;67 Suppl 1:S79–82.PubMedCrossRef
10.
Clements RH, Gonzalez QH, Foster A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.PubMedCrossRef
11.
Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99(9):1807–14.PubMedCrossRef
12.
Delgado-Aros S, Locke 3rd GR, Camilleri M, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.PubMedCrossRef
13.
Mathus-Vliegen EM, Tygat GN. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol. 2002;37(11):1246–52.PubMedCrossRef
14.
Levy RL, Linde JA, Feld KA, et al. The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol. 2005;3(10):992–6.PubMedCrossRef
15.
Talley NJ, Quan C, Jones MP, et al. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.PubMedCrossRef
16.
Vakil N. Body mass index and gastroesophageal reflux disease: implications of the obesity epidemic. Dig Dis Sci. 2008;53(9):2291–2.PubMedCrossRef
17.
Fishman L, Lenders C, Fortunato C, et al. Increased prevalence of constipation and fecal soiling in a population of obese children. J Pediatr. 2004;145(2):253–4.PubMedCrossRef
18.
Pashankar DS, Loening-Baucke V. Increased prevalence of obesity in children with functional constipation evaluated in an academic medical center. Pediatrics. 2005;116(3):e377–80.PubMedCrossRef
19.
Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, et al. Obesity and functional constipation; a community-based study in Iran. J Gastrointestin Liver Dis. 2009;18(2):151–5.PubMed
20.
Delgado-Aros S, Camilleri M, Garcia MA, et al. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G382–8.PubMedCrossRef
21.
22.
Catheline JM, Bihan H, Le Quang T, et al. Preoperative cardiac and pulmonary assessment in bariatric surgery. Obes Surg. 2008;18(3):271–7.PubMedCrossRef
23.
Bouchoucha M, Devroede G, Arsac M. Anismus: a marker of multi-site functional disorders? Int J Colorectal Dis. 2004;19(4):374–9.PubMedCrossRef
24.
Whitehead WE, Wald A, Diamant NE, et al. Functional disorders of the anus and rectum. Gut. 1999;45 Suppl 2:II55–1159.PubMedCrossRef
25.
Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12(7):439–45.PubMedCrossRef
26.
El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005;100(6):1243–50.PubMedCrossRef
27.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.PubMed
28.
Misra S, Lee A, Gensel K. Chronic constipation in overweight children. JPEN J Parenter Enteral Nutr. 2006;30(2):81–4.PubMedCrossRef
29.
Varma MG, Brown JS, Creasman JM, et al. Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum. 2006;49(6):841–51.PubMedCrossRef
30.
Wasserberg N, Haney M, Petrone P, et al. Morbid obesity adversely impacts pelvic floor function in females seeking attention for weight loss surgery. Dis Colon Rectum. 2007;50(12):2096–103.PubMedCrossRef
31.
Agrawal A, Whorwell PJ. Review article: abdominal bloating and distension in functional gastrointestinal disorders–epidemiology and exploration of possible mechanisms. Aliment Pharmacol Ther. 2008;27(1):2–10.PubMedCrossRef
32.
Teitelbaum JE, Sinha P, Micale M, et al. Obesity is related to multiple functional abdominal diseases. J Pediatr. 2009;154(3):444–6.PubMedCrossRef
33.
de Carvalho EB, Vitolo MR, Gama CM, et al. Fiber intake, constipation, and overweight among adolescents living in Sao Paulo City. Nutrition. 2006;22(7–8):744–9.PubMedCrossRef
34.
Cremonini F, Camilleri M, Clark MM, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009;33(3):342–53.CrossRef
35.
Chinn S. Obesity and asthma: evidence for and against a causal relation. J Asthma. 2003;40(1):1–16.PubMedCrossRef
36.
Gunnbjornsdottir MI, Omenaas E, Gislason T, et al. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J. 2004;24(1):116–21.PubMedCrossRef
37.
Kostikas K, Papaioannou AI, Gourgoulianis KI. BMI and gastroesophageal reflux in women. N Engl J Med. 2006;355(8):848. author reply 9–50.PubMedCrossRef
38.
Dixon AE, Shade DM, Cohen RI, et al. Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma. 2006;43(7):553–8.PubMedCrossRef
39.
Kasasbeh A, Kasasbeh E, Krishnaswamy G. Potential mechanisms connecting asthma, esophageal reflux, and obesity/sleep apnea complex–a hypothetical review. Sleep Med Rev. 2007;11(1):47–58.PubMedCrossRef
40.
Kim HJ, Yoo TW, Park DI, et al. Influence of overweight and obesity on upper endoscopic findings. J Gastroenterol Hepatol. 2007;22(4):477–81.PubMedCrossRef
41.
Kang MS, Park DI, Oh SY, et al. Abdominal obesity is an independent risk factor for erosive esophagitis in a Korean population. J Gastroenterol Hepatol. 2007;22(10):1656–61.PubMedCrossRef
42.
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53(9):2307–12.PubMedCrossRef
43.
Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007;56(6):756–62.PubMedCrossRef
44.
El-Serag HB, Ergun GA, Pandolfino J, et al. Obesity increases oesophageal acid exposure. Gut. 2007;56(6):749–55.PubMedCrossRef
45.
Pandolfino JE, El-Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130(3):639–49.PubMedCrossRef
46.
Locke 3rd GR, Zinsmeister AR, Fett SL, et al. Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil. 2005;17(1):29–34.PubMedCrossRef
47.
Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98(11):2454–9.PubMedCrossRef
48.
Tack J. Is there a unifying role for visceral hypersensitivity and irritable bowel syndrome in nonerosive reflux disease? Digestion. 2008;78 Suppl 1:42–5.PubMedCrossRef
49.
Pimentel M, Rossi F, Chow EJ, et al. Increased prevalence of irritable bowel syndrome in patients with gastroesophageal reflux. J Clin Gastroenterol. 2002;34(3):221–4.PubMedCrossRef
50.
Hershcovici T, Zimmerman J. Nondigestive symptoms in non-erosive reflux disease: nature, prevalence and relation to acid reflux. Aliment Pharmacol Ther. 2008;28(9):1127–33.PubMedCrossRef
51.
Xing J, Chen JD. Alterations of gastrointestinal motility in obesity. Obes Res. 2004;12(11):1723–32.PubMedCrossRef
52.
van Oijen MG, Josemanders DF, Laheij RJ, et al. Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med. 2006;64(2):45–9.PubMed
53.
Erekson EA, Sung VW, Myers DL. Effect of body mass index on the risk of anal incontinence and defecatory dysfunction in women. Am J Obstet Gynecol. 2008;198(5):596 e1–4.CrossRef
54.
Abramov Y, Sand PK, Botros SM, et al. Risk factors for female anal incontinence: new insight through the Evanston-Northwestern twin sisters study. Obstet Gynecol. 2005;106(4):726–32.PubMedCrossRef
55.
Greer WJ, Richter HE, Bartolucci AA, et al. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol. 2008;112(2 Pt 1):341–9.PubMedCrossRef
56.
Murphy JM, Horton NJ, Burke Jr JD, et al. Obesity and weight gain in relation to depression: findings from the Stirling County Study. Int J Obes Lond. 2009;33(3):335–41.PubMedCrossRef
57.
Chen Y, Jiang Y, Mao Y. Association between obesity and depression in Canadians. J Womens Health Larchmt. 2009;18(10):1687–92.PubMedCrossRef
58.
Brown R, Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint. Adv Neurol. 1995;65:61–84.PubMed
59.
Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005;52(5):1577–84.PubMedCrossRef
60.
Hendricks EJ, Rothman RB, Greenway FL. How physician obesity specialists use drugs to treat obesity. Obes Silver Spring. 2009;17(9):1730–5.CrossRef
61.
Rahimi R, Nikfar S, Rezaie A, et al. Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol. 2009;15(13):1548–53.PubMedCrossRef
62.
Martinez SD, Malagon IB, Garewal HS, et al. Non-erosive reflux disease (NERD)–acid reflux and symptom patterns. Aliment Pharmacol Ther. 2003;17(4):537–45.PubMedCrossRef
63.
Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology. 1992;102(4 Pt 1):1259–68.PubMed
64.
Decker GA, DiBaise JK, Leighton JA, et al. Nausea, bloating and abdominal pain in the Roux-en-Y gastric bypass patient: more questions than answers. Obes Surg. 2007;17(11):1529–33.PubMedCrossRef
Metadata
Title
Prevalence and Co-occurrence of Upper and Lower Functional Gastrointestinal Symptoms in Patients Eligible for Bariatric Surgery
Authors
Marinos Fysekidis
Michel Bouchoucha
Hélène Bihan
Gérard Reach
Robert Benamouzig
Jean-Marc Catheline
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 3/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0396-z

Other articles of this Issue 3/2012

Obesity Surgery 3/2012 Go to the issue

Letter to the Editor

Bariatric Surgery and Diabetic Retinopathy: a Pilot Analysis

Letter to the Editor

Letter to the Editor: Long-Term Experience with Duodenal Switch in Adolescents

Animal Research

Myocardial Insulin Signaling and Glucose Transport Are Up-regulated in Goto–Kakizaki Type 2 Diabetic Rats After Ileal Transposition

Other

An Analysis of 1–3-Year Follow-up Results of Laparoscopic Sleeve Gastrectomy: an Indian Perspective

Clinical Research

Functional Importance of Laparoscopic Sleeve Gastrectomy for the Lower Esophageal Sphincter in Patients with Morbid Obesity

Clinical Research

Revisiting the Revised Master Questionnaire for the Psychological Evaluation of Bariatric Surgery Candidates